Skip to main content
Normal View

National Cancer Strategy

Dáil Éireann Debate, Wednesday - 21 April 2021

Wednesday, 21 April 2021

Questions (2086)

John Lahart

Question:

2086. Deputy John Lahart asked the Minister for Health his position in relation to the national cancer strategy and placing Ireland in the top quartile in Europe for cancer survival; and if he will make a statement on the matter. [19793/21]

View answer

Written answers

The implementation of the National Cancer Strategy is a Programme for Government commitment, and is part of the implementation of Sláintecare. We have seen significant progress on the implementation of the Strategy over the past three years, with clear evidence-based policy direction from my Department and strong implementation by the HSE's National Cancer Control Programme.

Much progress has been made in cancer survival rates. The most recent available data from the National Cancer Registry Ireland (NCRI) shows that five-year survival rates for all cancers increased from 42% (1994-1999) to 63% (2012-2016). However, there is a time lag in the compilation of such figures and in calculating international comparisons. Meanwhile, the number of cancer survivors continues to increase, with over 200,000 people who have been previously diagnosed with an invasive cancer now living n Ireland.

Improvements in survival and outcomes are largely attributable to earlier detection and improvements in treatment. The National Cancer Strategy seeks to build on the successes of previous strategies in the areas of prevention, early diagnosis and treatment, while also working to maximise the quality of life for patients living with and beyond a cancer diagnosis. As indicated, it is an aim of the Strategy for survival rates in Ireland to be within the top quartile of European countries by the end of the Strategy period (2026).

A allocation of €20m has been made for the continued implementation of the National Cancer Strategy this year. This funding will facilitate significant progression of key priorities, including prevention measures, improved access to diagnostics, the further development of medical, radiation and surgical oncology and expanded services to support those living with and beyond cancer.

Top
Share